LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | R406 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3367 | 4093 | 0.8227 | 0.7483 |
MCF7 | Pictilisib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1112 | 4093 | 0.2717 | -0.0338 |
MCF7 | Gefitinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3922 | 4093 | 0.9584 | 0.9409 |
MCF7 | Geldanamycin | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1071 | 4093 | 0.2618 | -0.0478 |
MCF7 | Geldanamycin | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1126 | 4093 | 0.2752 | -0.0289 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1029 | 4093 | 0.2516 | -0.0624 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 986 | 4093 | 0.2410 | -0.0774 |
MCF7 | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1999 | 4093 | 0.4884 | 0.2738 |
MCF7 | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1073 | 4093 | 0.2622 | -0.0472 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1828 | 4093 | 0.4466 | 0.2145 |
MCF7 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1310 | 4093 | 0.3201 | 0.0348 |
MCF7 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1316 | 4093 | 0.3215 | 0.0369 |
MCF7 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1982 | 4093 | 0.4843 | 0.2680 |
MCF7 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3840 | 4093 | 0.9382 | 0.9123 |
MCF7 | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1209 | 353 | 4093 | 0.0862 | -0.2971 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1326 | 4093 | 0.3241 | 0.0405 |
MCF7 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3577 | 4093 | 0.8740 | 0.8212 |
MCF7 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1209 | 967 | 4093 | 0.2363 | -0.0841 |
MCF7 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 3423 | 4093 | 0.8365 | 0.7679 |
MCF7 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1932 | 4093 | 0.4720 | 0.2506 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1209 | 530 | 4093 | 0.1296 | -0.2356 |
MCF7 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1209 | 499 | 4093 | 0.1219 | -0.2464 |
MCF7 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1618 | 4093 | 0.3953 | 0.1417 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1390 | 4093 | 0.3396 | 0.0626 |
MCF7 | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 3829 | 4093 | 0.9357 | 0.9087 |